Autolus Therapeutics Announces Changes to its Board of Directors

January 19, 2024

https://www.globenewswire.com/news-release/2023/12/22/2800539/0/en/Autolus-Therapeutics-Announces-Changes-to-its-Board-of-Directors.html

–  Appointment of Elisabeth (“Lis”) Leiderman, M.D.

–  Resignation of Kapil Dhingra, M.D.

LONDON, Dec. 22, 2023 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the appointment of Elisabeth Leiderman, M.D. to the Board of Directors. Additionally, the Company announced that Kapil Dhingra M.D., who has served on Autolus’ Board of Directors since May 2015, has advised the Board of his intent to step down from his role as a member of the Board and chair of the Nominating and Corporate Governance Committee of the Board, effective December 31, 2023.

Read more at globenewswire.com

Related news for (AUTL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.